Home and Personal Care, Healthcare segments perform well; beverages see dip, leading to low single-digit revenue growth forecast.

Dabur India has released its preliminary business update for Q1 FY26, indicating low single-digit revenue growth for the quarter ended June 30, 2025. The muted performance is primarily attributed to declining beverage sales, impacted by unseasonal rains and a shorter summer.

Despite this, Dabur noted strong momentum in its Home and Personal Care (HPC) and Healthcare segments. Key HPC brands such as Dabur Red Toothpaste, Odonil, Odomos, and Gulabari showed robust performance, contributing to market share gains. The healthcare portfolio, featuring Dabur Honey, Hajmola, Honitus, and Dabur Health Juices, also witnessed double-digit growth, with Honitus alone expected to clock over 40% growth.

Urban demand recovery supported Dabur’s performance, particularly across organised trade channels like e-commerce, quick commerce, and modern trade. The company’s international business also reported double-digit constant currency growth, led by MENA, Turkey, Bangladesh, and the US (Namaste).

However, the beverage portfolio suffered, dragging down overall revenue. While the broader category declined, products like Activ Juices and Activ Coconut Water still achieved mid-teen growth. Dabur plans to increase focus on the Activ range to align with year-round demand and reduce reliance on seasonal peaks.

Operating profit growth is expected to slightly trail revenue growth. Looking ahead, Dabur remains optimistic, citing favourable macroeconomic indicators-including a strong monsoon, easing inflation, and rising rural demand-as tailwinds for the remainder of FY26. Strategic investments in brand building, distribution, and operational efficiencywill remain central to its growth strategy.